Abstract

IntroductionOlaparib is an oral poly (ADP-ribose) polymerase inhibitor that has shown antitumor activity in patients with advance or recurrent ovarian cancer. It is associated with adverse side effects, including fatigue,...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
How to approach patients in relapse
E Pujade-Lauraine
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 23
E Pujade-LauraineE Pujade-Lauraine
01 Sep 2012
1000P - Efficacy and safety of oral poly (ADP-ribose) polymerase inhibitor fluzoparib in patients with BRCA1/2 mutations and platinum sensitive recurrent ovarian cancer
N Li ... Q Wang
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
N Li, et. al.N Li ... Q Wang
01 Oct 2019
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study
Rafli Van De Laar ... Petra Lm Zusterzeel
BMC Cancer | VOL. 14
Rafli Van De Laar, et. al.Rafli Van De Laar ... Petra Lm Zusterzeel
14 Jan 2014
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Are we making progress in curing advanced cervical cancer—again?
Jacob Christian Lindegaard ... Richard Pötter
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Jacob Christian Lindegaard, et. al.Jacob Christian Lindegaard ... Richard Pötter
09 Jul 2024
Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome
Barin Feroz ... Verena Wieser
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Barin Feroz, et. al.Barin Feroz ... Verena Wieser
03 Jul 2024
Robotic staging for early ovarian cancer in 10 steps
Aniello Foresta ... Valerio Gallotta
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Aniello Foresta, et. al.Aniello Foresta ... Valerio Gallotta
01 Jul 2024
Measuring the impact of specific surgical complications after ovarian cancer cytoreductive surgery on short-term outcomes
Arwa Mohammad ... William Cliby
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Arwa Mohammad, et. al.Arwa Mohammad ... William Cliby
01 Jul 2024
View more papers